Cephalosporin resistance among animal-associated Enterobacteria: a current perspective

References

• Hornish RE, Kotarski SF. Cephalosporins in veterinary medicine – ceftiofur use in food animals. Curr. Top. Med. Chem. 2(7), 717–731 (2002).
   PubMedGoogle Scholar
• Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46(1), 1–11 (2002).
   PubMed Web of Science ®Google Scholar
• Livermore DM. β-lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41(Suppl. D), 25–41 (1998).
   PubMedGoogle Scholar
• Bush K. Characterization of β-lactamases. Antimicrob. Agents Chemother. 33(3), 259–263 (1989).
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39(6), 1211–1233 (1995).
   PubMed Web of Science ®Google Scholar
• Ambler RP. The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 289(1036), 321–331 (1980).
   PubMed Web of Science ®Google Scholar
• National Office of Animal Health Ltd (NOAH). Compendium of data sheets for veterinary products. (2004).
   Google Scholar
• Allen KJ, Poppe C. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by β-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can. J. Vet. Res. 66(3), 137–144 (2002).
   PubMedGoogle Scholar
• Winokur PL, Brueggemann A, DeSalvo DL et al. Animal and human multi-drug resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob. Agents Chemother. 44(10), 2777–2783 (2000).
   PubMedGoogle Scholar
• Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health. Uses of antimicrobials in food animals in Canada: impact on resistance and human health. (2002).
   Google Scholar
• Livermore DM. β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8(4), 557–584 (1995).
   PubMed Web of Science ®Google Scholar
• Sougakoff W, Goussard S, Courvalin P. The TEM-3 β-lactamase, which hydrolyzes broad spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiol. Lett. 56(3), 343–348 (1988).
   Google Scholar
• Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14(4), 933–951 (2001).
   PubMed Web of Science ®Google Scholar
• Vakulenko SB, Geryk B, Kotra LP et al. Selection and characterization of β-lactam-β-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 β-lactamase gene. Antimicrob. Agents Chemother. 42(7), 1542–1548 (1998).
   PubMed Web of Science ®Google Scholar
• Helfand MS, Bethel CR, Hujer AM et al. Understanding resistance to β-lactams and β-lactamase inhibitors in the SHV β-lactamase: lessons from the mutagenesis of SER-130. J. Biol. Chem. 278(52), 52724–52729 (2003).
   PubMedGoogle Scholar
• Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48(1), 1–14 (2004).
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Høiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can. J. Microbiol. 50(3), 137–165 (2004).
   PubMedGoogle Scholar
• Matsumoto Y, Ikeda F, Kamimura T et al. Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob. Agents Chemother. 32(8), 1243–1246 (1988).
   PubMed Web of Science ®Google Scholar
• Humeniuk C, Arlet G, Gautier V et al. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46(9), 3045–3049 (2002).
   PubMed Web of Science ®Google Scholar
• Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrob. Agents Chemother. 45(12), 3595–3598 (2001).
   PubMed Web of Science ®Google Scholar
• Poirel L, Kämpfer P, Nordmann P. Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 46(12), 4038–4040 (2002).
   PubMed Web of Science ®Google Scholar
• Lartigue MF, Poirel L, Nordmann P. Diversity of genetic environment of bla(CTX-M) genes. FEMS Microbiol. Lett. 234(2), 201–207 (2004).
   PubMed Web of Science ®Google Scholar
• Fosse T, Giraud-Morin C, Madinier I et al. Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC ‘FOX’ cluster. FEMS Microbiol. Lett. 222(1), 93–98 (2003).
   PubMedGoogle Scholar
• Bauernfeind A, Stemplinger I, Jungwirth R et al. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40(1), 221–224 (1996).
   PubMedGoogle Scholar
• Poirel L, Guibert M, Girlich D et al. Cloning, sequence analyses, expression, and distribution of ampC–ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43(4), 769–776 (1999).
   PubMedGoogle Scholar
• Girlich D, Naas T, Bellais S et al. Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob. Agents Chemother. 44(6), 1470–1478 (2000).
   PubMed Web of Science ®Google Scholar
• Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34(11), 2200–2209 (1990).
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40(6), 2153–2162 (2002).
   PubMed Web of Science ®Google Scholar
• Yan JJ, Chiu CH, Ko WC et al. Ceftriaxone-resistant Salmonella enterica serovar Hadar: evidence for interspecies transfer of blaCMY-2 in a Taiwanese university hospital. J. Formos. Med. Assoc. 101(9), 665–668 (2002).
   PubMed Web of Science ®Google Scholar
• Koeck JL, Arlet G, Philippon A et al. A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152(2), 255–260 (1997).
   PubMedGoogle Scholar
• Chen S, Zhao S, White DG et al. Characterization of multiple antimicrobial-resistant Salmonella serovars isolated from retail meats. Appl. Environ. Microbiol. 70(1), 1–7 (2004).
   PubMed Web of Science ®Google Scholar
• Armand-Lefèvre L, Leflon-Guibout V, Bredin J et al. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production. Antimicrob. Agents Chemother. 47(3), 1165–1168 (2003).
   PubMedGoogle Scholar
• Miriagou V, Filip R, Coman G et al. Expanded-spectrum cephalosporin-resistant Salmonella strains in Romania. J. Clin. Microbiol. 40(11), 4334–4336 (2002).
   PubMed Web of Science ®Google Scholar
• Navarro F, Perez-Trallero E, Marimon JM et al. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999–December 2000). J. Antimicrob. Chemother. 48(3), 383–389 (2001).
   PubMedGoogle Scholar
• Orman BE, Pineiro SA, Arduino S et al. Evolution of multiresistance in nontyphoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46(12), 3963–3970 (2002).
   PubMed Web of Science ®Google Scholar
• Chiu CH, Su LH, Chu C et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 363(9417), 1285–1286 (2004).
   PubMed Web of Science ®Google Scholar
• Giles WP, Benson AK, Olson ME et al. DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones. Antimicrob. Agents Chemother. 48(8), 2845–2852 (2004).
   PubMedGoogle Scholar
• Carattoli A, Tosini F, Giles WP et al. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46(5), 1269–1272 (2002).
   PubMedGoogle Scholar
• Hanson ND. AmpC β-lactamases: what do we need to know for the future? J. Antimicrob. Chemother. 52(1), 2–4 (2003).
   PubMed Web of Science ®Google Scholar
• Petrosino JF, Pendleton AR, Weiner JH et al. Chromosomal system for studying AmpC-mediated β-lactam resistance mutation in Escherichia coli. Antimicrob. Agents Chemother. 46(5), 1535–1539 (2002).
   PubMedGoogle Scholar
• Hanson ND, Sanders CC. Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr. Pharm. Des. 5(11), 881–894 (1999).
   PubMed Web of Science ®Google Scholar
• Lindberg F, Lindquist S, Normark S. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii β-lactamase. J. Bacteriol. 169(5), 1923–1928 (1987).
   PubMedGoogle Scholar
• Jaurin B, Grundström T, Edlund T et al. The E. coli β-lactamase attenuator mediates growth rate-dependent regulation. Nature 290(5803), 221–225 (1981).
   PubMed Web of Science ®Google Scholar
• Olsson O, Bergström S, Lindberg FP et al. ampC β-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. USA 80(24), 7556–7560 (1983).
   PubMed Web of Science ®Google Scholar
• Edlund T, Grundstrom T, Normark S. Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K-12. Mol. Gen. Genet. 173(2), 115–125 (1979).
   PubMedGoogle Scholar
• Edlund T, Normark S. Recombination between short DNA homologies causes tandem duplication. Nature 292(5820), 269–271 (1981).
   PubMedGoogle Scholar
• Olsson O, Bergström S, Normark S. Identification of a novel ampC β-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J. 1(11), 1411–1416 (1982).
   PubMed Web of Science ®Google Scholar
• Nelson EC, Elisha BG. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43(4), 957–959 (1999).
   PubMedGoogle Scholar
• Caroff N, Espaze E, Bérard I et al. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production. FEMS Microbiol. Lett. 173(2), 459–465 (1999).
   PubMedGoogle Scholar
• Caroff N, Espaze E, Gautreau D et al. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45(6), 783–788 (2000).
   PubMed Web of Science ®Google Scholar
• Siu LK, Lu PL, Chen JY et al. High-level expression of ampC β-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum cephalosporin treatment. Antimicrob. Agents Chemother. 47(7), 2138–2144 (2003).
   PubMedGoogle Scholar
• Reisbig MD, Hossain A, Hanson ND. Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. J. Antimicrob. Chemother. 51(5), 1141–1151 (2003).
   PubMed Web of Science ®Google Scholar
• Naas T, Nordmann P. OXA-type β-lactamases. Curr. Pharm. Des. 5(11), 865–879 (1999).
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez L, Conejo MC, Pascual A et al. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles. Antimicrob. Agents Chemother. 44(9), 2534–2536 (2000).
   PubMed Web of Science ®Google Scholar
• Bradford PA, Urban C, Mariano N et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 41(3), 563–569 (1997).
   PubMed Web of Science ®Google Scholar
• Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43(5), 1206–1210 (1999).
   PubMed Web of Science ®Google Scholar
• Briñas L, Moren MA, Teshager T et al. β-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain. Microb. Drug Resist. 9(2), 201–209 (2003).
   PubMedGoogle Scholar
• Briñas L, Moreno MA, Zarazaga M et al. Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob. Agents Chemother. 47(6), 2056–2058 (2003).
   PubMedGoogle Scholar
• Liebana E, Gibbs M, Clouting C et al. Characterization of β-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb. Drug Resist. 10(1), 1–9 (2004).
   PubMedGoogle Scholar
• Aarestrup FM, Hasman H, Olsen I et al. International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada. Antimicrob. Agents Chemother. 48(5), 1916–1917 (2004).
   PubMedGoogle Scholar
• Gupta A, Fontana J, Crowe C et al. Emergence of multi-drug resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J. Infect. Dis. 188(11), 1707–1716 (2003).
   PubMed Web of Science ®Google Scholar
• Dunne EF, Fey PD, Kludt P et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. J. Am. Med. Assoc. 284(24), 3151–3156 (2000).
   PubMed Web of Science ®Google Scholar
• Shiraki Y, Shibata N, Doi Y et al. Escherichia coli producing CTX-M-2 β-lactamase in cattle, Japan. Emerg. Infect. Dis. 10(1), 69–75 (2004).
   PubMedGoogle Scholar
• Yan JJ, Hong CY, Ko WC et al. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob. Agents Chemother. 48(4), 1353–1356 (2004).
   PubMed Web of Science ®Google Scholar
• Briñas L, Zarazaga M, Sáenz Y et al. β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob. Agents Chemother. 46(10), 3156–3163 (2002).
   PubMed Web of Science ®Google Scholar
• Randall LP, Cooles SW, Osborn MK et al. Antibiotic resistance genes, integrons and multiple antibiotic resistance in thirty-five serotypes of Salmonella enterica isolated from humans and animals in the UK. J. Antimicrob. Chemother. 53(2), 208–216 (2004).
   PubMedGoogle Scholar
• Antunes P, Machado J, Sousa JC et al. Dissemination amongst humans and food products of animal origin of a Salmonella typhimurium clone expressing an integron-borne OXA-30 β-lactamase. J. Antimicrob. Chemother. 54(2), 429–434 (2004).
   PubMedGoogle Scholar
• Guerra B, Junker E, Schroeter A et al. Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry. J. Antimicrob. Chemother. 52(3), 489–492 (2003).
   PubMed Web of Science ®Google Scholar
• Bradford PA, Petersen PJ, Fingerman IM et al. Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. J. Antimicrob. Chemother. 44(5), 607–610 (1999).
   PubMed Web of Science ®Google Scholar
• Olesen I, Hasman H, Aarestrup FM. Prevalence of β-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microb. Drug Resist. 10(4), 334–340 (2004).
   PubMedGoogle Scholar
• Féria C, Ferreira E, Correia JD et al. Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J. Antimicrob. Chemother. 49(1), 77–85 (2002).
   PubMedGoogle Scholar
• Maidhof H, Guerra B, Abbas S et al. A multiresistant clone of Shiga toxin-producing Escherichia coli O118:[H16] is spread in cattle and humans over different European countries. Appl. Environ. Microbiol. 68(12), 5834–5842 (2002).
   PubMedGoogle Scholar
• Dundas S, Todd WT. Clinical presentation, complications and treatment of infection with verocytotoxin-producing Escherichia coli. Challenges for the clinician. Symp. Ser. Soc. Appl. Microbiol. (29), S24–S30 (2000).
   PubMedGoogle Scholar
• Weill FX, Lailler R, Praud K et al. Emergence of extended-spectrum β-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J. Clin. Microbiol. 42(12), 5767–5773 (2004).
   PubMed Web of Science ®Google Scholar
• Teshager T, Domínguez L, Moreno MA et al. Isolation of an SHV-12 β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections. Antimicrob. Agents Chemother. 44(12), 3483–3484 (2000).
   PubMedGoogle Scholar
• Costa D, Poeta P, Briñas L et al. Detection of CTX-M-1 and TEM-52 β-lactamases in Escherichia coli from healthy pets in Portugal. J. Antimicrob. Chemother. 54(5), 960–961 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao S, White DG, McDermott PF et al. Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob. Agents Chemother. 45(12), 3647–3650 (2001).
   PubMed Web of Science ®Google Scholar
• Fey PD, Safranek TJ, Rupp ME et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342(17), 1242–1249 (2000).
   PubMed Web of Science ®Google Scholar
• Rankin SC, Aceto H, Cassidy J et al. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J. Clin. Microbiol. 40(12), 4679–4684 (2002).
   PubMedGoogle Scholar
• White DG, Zhao S, Sudler R et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. N. Engl. J. Med. 345(16), 1147–1154 (2001).
   PubMed Web of Science ®Google Scholar
• Zhao S, Qaiyumi S, Friedman S et al. Characterization of Salmonella enterica serotype newport isolated from humans and food animals. J. Clin. Microbiol. 41(12), 5366–5371 (2003).
   PubMed Web of Science ®Google Scholar
• Winokur PL, Vonstein DL, Hoffman LJ et al. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45(10), 2716–2722 (2001).
   PubMed Web of Science ®Google Scholar
• Department of Agriculture Athens Georgia, USA. National Antimicrobial Resistance Monitoring System (NARMS): Enteric Bacteria Veterinary Salmonella report 2003. (2004).
   Google Scholar
• Gray JT, Hungerford LL, Fedorka-Cray PJ et al. Extended-spectrum-cephalosporin resistance in Salmonella enterica isolates of animal origin. Antimicrob. Agents Chemother. 48(8), 3179–3181 (2004).
   PubMedGoogle Scholar
• Guardabassi L, Schwarz, S Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria. J. Antimicrob. Chemother. 54(2), 321–332 (2004).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention Atlanta, USA. National Antimicrobial Resistance Monitoring System (NARMS): Enteric Bacteria Annual report 2002. (2004).
   Google Scholar
• Department for Environment Food and Rural Affairs UK. (DEFRA). Salmonella in livestock production in GB. (2003).
   Google Scholar
• Espié E, Weill FX. Outbreak of multi-drug resistant Salmonella Newport due to the consumption of horsemeat in France. Eurosurveillance 7(27), (2003).
   Google Scholar
• Miriagou V, Tassios PT, Legakis NJ et al. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int. J. Antimicrob. Agents 23(6), 547–555 (2004).
   PubMed Web of Science ®Google Scholar
• Hohmann EL. Nontyphoidal salmonellosis. Clin. Infect. Dis. 32(2), 263–269 (2001).
   PubMed Web of Science ®Google Scholar
• Ko WC, Yan JJ, Yu WL et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin. Infect. Dis. 40(2), 315–318 (2005).
   PubMedGoogle Scholar
• Wong-Beringer A. Therapeutic challenges associated with extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Pharmacotherapy 21(5), 583–592 (2001).
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Munoz-Price LS. The new β-lactamases. N. Engl. J. Med. 352(4), 380–391 (2005).
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8(6), 321–331 (2002).
   PubMed Web of Science ®Google Scholar
• Miriagou V, Tzouvelekis LS, Rossiter S et al. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47(4), 1297–1300 (2003).
   PubMed Web of Science ®Google Scholar
• Neuwirth C, Siebor E, Pechinot A et al. Evidence of in vivo transfer of a plasmid encoding the extended-spectrum β-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae. J. Clin. Microbiol. 39(5), 1985–1988 (2001).
   PubMedGoogle Scholar
• Sanchez S, McCrackin Stevenson MA, Hudson CR et al. Characterization of multi-drug resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 40(10), 3586–3595 (2002).
   PubMed Web of Science ®Google Scholar
• Jaurin B, Grundström T, Normark S. Sequence elements determining ampC promoter strength in E. coli. EMBO J. 1(7), 875–881 (1982).
   PubMed Web of Science ®Google Scholar
• Anderson AD, Nelson JM, Rossiter S et al. Public health consequences of use of antimicrobial agents in food animals in the United States. Microb. Drug Resist. 9(4), 373–379 (2003).
   PubMed Web of Science ®Google Scholar
• Danish Institute for Food and Veterinary Research. DANMAP 2003: use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. (2004).
   Google Scholar
• The National Veterinary Institute Uppsala Sweden. SVARM 2003: Swedish veterinary antimicrobial resistance monitoring. (2003).
   Google Scholar
• Veterinary Medicines Directorate (UK). Sales of antimicrobial products authorised for use as veterinary medicines, antiprotozoals, antifungals, growth promoters and coccidiostats, in the UK. (2004).
   Google Scholar
• Doublet B, Carattoli A, Whichard JM et al. Plasmid-mediated florfenicol and ceftriaxone resistance encoded by the floR and bla(CMY-2) genes in Salmonella enterica serovars Typhimurium and Newport isolated in the United States. FEMS Microbiol. Lett. 233(2), 301–305 (2004).
   PubMed Web of Science ®Google Scholar
• Centraal Instituut voor Dierziekt Controle (CIDC-Lelystad). MARAN 2002: monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2002. (2004).
   Google Scholar
• Sarria JC, Vidal AM, Kimbrough RC III. Infections caused by Kluyvera species in humans. Clin. Infect. Dis. 33(7), E69–E74 (2001).
   PubMedGoogle Scholar
• Moubareck C, Bourgeois N, Courvalin P et al. Multiple antibiotic resistance gene transfer from animal to human enterococci in the digestive tract of gnotobiotic mice. Antimicrob. Agents Chemother. 47(9), 2993–2996 (2003).
   PubMed Web of Science ®Google Scholar
• Bourgeois N, Savard B, Moubareck C et al. Interspecies transfer of vancomycin resistance from poultry Enterococcus faecium to human Enterococcus faecalis in digestive tract of human flora associated mice. 43rd ICCAC abstracts. ASM. IL, USA (2003).
   Google Scholar
• Shoemaker NB, Wang GR, Salyers AA. Evidence for natural transfer of a tetracycline resistance gene between bacteria from the human colon and bacteria from the bovine rumen. Appl. Environ. Microbiol. 58(4), 1313–1320 (1992).
   PubMedGoogle Scholar
• Oppegaard H, Steinum TM, Wasteson Y. Horizontal transfer of a multi-drug resistance plasmid between coliform bacteria of human and bovine origin in a farm environment. Appl. Environ. Microbiol. 67(8), 3732–3734 (2001).
   PubMed Web of Science ®Google Scholar
• Su LH, Chiu CH, Chu C et al. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum. Antimicrob. Agents Chemother. 47(2), 563–567 (2003).
   PubMed Web of Science ®Google Scholar
• Archambaud M, Gerbaud G, Labau E et al. Possible in vivo transfer of β-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J. Antimicrob. Chemother. 27(4), 427–436 (1991).
   PubMedGoogle Scholar
• Bergström S, Lindberg FP, Olsson O et al. Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other Gram-negative bacteria. J. Bacteriol. 155(3), 1297–1305 (1983).
   PubMed Web of Science ®Google Scholar
• Honore N, Nicolas MH, Cole ST. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J. 5(13), 3709–3714 (1986).
   PubMed Web of Science ®Google Scholar
• Barnaud G, Arlet G, Verdet C et al. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42(9), 2352–2358 (1998).
   PubMedGoogle Scholar
• Fortineau N, Poirel L, Nordmann P. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47(2), 207–210 (2001).
   PubMedGoogle Scholar
• Reisbig MD, Hanson ND. The ACT-1 plasmid-encoded AmpC β-lactamase is inducible: detection in a complex β-lactamase background. J. Antimicrob. Chemother. 49(3), 557–560 (2002).
   PubMedGoogle Scholar
• Nakano R, Okamoto R, Nakano Y et al. CFE-1, a novel plasmid-encoded AmpC β-lactamase with an ampR gene originating from Citrobacter freundii. Antimicrob. Agents Chemother. 48(4), 1151–1158 (2004).
   PubMedGoogle Scholar
• Morosini MI, Ayala JA, Baquero F et al. Biological cost of AmpC production for Salmonella enterica serotype typhimurium. Antimicrob. Agents Chemother. 44(11), 3137–3143 (2000).
   PubMed Web of Science ®Google Scholar
• Hossain A, Reisbig MD, Hanson ND. Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium. J. Antimicrob. Chemother. 53(6), 964–970 (2004).
   PubMedGoogle Scholar
• Maurelli AT, Fernández RE, Bloch CA et al. ‘Black holes’ and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. USA 95(7), 3943–3948 (1998).
   PubMed Web of Science ®Google Scholar
• Zansky S, Wallace B, Schoonmaker-Bopp D et al. From the Centers for Disease Control and Prevention. Outbreak of multi-drug resistant Salmonella Newport – United States January–April 2002. J. Am. Med. Assoc. 288(8), 951–953 (2002).
   Google Scholar
• Pitout JD, Reisbig MD, Mulvey M et al. Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC β-lactamase CMY-2. J. Clin. Microbiol. 41(10), 4578–4582 (2003).
   PubMed Web of Science ®Google Scholar